Pedro Perez: Has Computer-Assisted Thrombectomy Actually Improved Patient Care, Or Simply Improved the Tools?
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Today, we’re entering another shift with Computer Assisted Vacuum Thrombectomy (CAVT) and technologies capable of tissue identification – allowing physicians to distinguish between circulating blood and organized thrombus.
Companies are pushing this tech forward, building on the early work pioneered by physicians.
But the bigger question is this:
Has computer-assisted thrombectomy actually improved patient care… or simply improved the tools?
If these technologies truly deliver greater procedural efficiency, reduced blood loss, and more precise clot removal, then we may be witnessing the next meaningful evolution in VTE treatment.
Curious to hear from others in the field – Are we seeing better outcomes, or just better technology?”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization